4.1 Review

EGFR Analysis: Current Evidence and Future Directions

Related references

Note: Only part of the references are listed.
Article

Mutation specific antibodies: tool or dinosaur?

Andreas von Deimling et al.

Oncotarget (2015)

Review Oncology

The evolving genomic classification of lung cancer

David S. Shames et al.

JOURNAL OF PATHOLOGY (2014)

Article Medical Laboratory Technology

Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors

Neal I. Lindeman et al.

ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2013)

Review Oncology

Next-generation sequencing in the clinic: Promises and challenges

Jiekun Xuan et al.

CANCER LETTERS (2013)

Article Medical Laboratory Technology

Cytomorphologic features of advanced lung adenocarcinomas tested for EGFR and KRAS mutations: A retrospective review of 50 cases

Jonathan D. Marotti et al.

DIAGNOSTIC CYTOPATHOLOGY (2013)

Article Medical Laboratory Technology

Evaluation of EGFR Mutation Status in Cytology Specimens: An Institutional Experience

D. L. Aisner et al.

DIAGNOSTIC CYTOPATHOLOGY (2013)

Article Medical Laboratory Technology

Epidermal growth factor receptor and Kras gene expression: Reliability of mutational analysis on cytological samples

Cecilia Bozzetti et al.

DIAGNOSTIC CYTOPATHOLOGY (2013)

Article Medical Laboratory Technology

Applications and limitations of oncogene mutation testing in clinical cytopathology

Claudio Bellevicine et al.

SEMINARS IN DIAGNOSTIC PATHOLOGY (2013)

Article Pathology

Semiautomated Laser Capture Microdissection of Lung Adenocarcinoma Cytology Samples

Sinchita Roy Chowdhuri et al.

ACTA CYTOLOGICA (2012)

Article Pathology

Molecular Pathology of Non-Small Cell Lung Cancer A Practical Guide

Dara L. Aisner et al.

AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2012)

Article Medical Laboratory Technology

Cytological cell blocks: Predictors of squamous cell carcinoma and adenocarcinoma subtypes

Kristina Loukeris et al.

DIAGNOSTIC CYTOPATHOLOGY (2012)

Review Medical Laboratory Technology

The role of cytology specimens in molecular testing of solid tumors: Techniques, limitations, and opportunities

Dara L. Aisner et al.

DIAGNOSTIC CYTOPATHOLOGY (2012)

Article Pathology

EGFR and KRAS mutations detection on lung cancer liquid-based cytology: a pilot study

Umberto Malapelle et al.

JOURNAL OF CLINICAL PATHOLOGY (2012)

Article Pathology

EGFR mutations detection on liquid-based cytology: is microscopy still necessary?

Umberto Malapelle et al.

JOURNAL OF CLINICAL PATHOLOGY (2012)

Review Pharmacology & Pharmacy

Pharmacogenetics of EGFR in lung cancer: perspectives and clinical applications

Clara Mayo et al.

PHARMACOGENOMICS (2012)

Article Anatomy & Morphology

EGFR Mutation-specific Antibodies in Pulmonary Adenocarcinoma: A Comparison With DNA Direct Sequencing

Andrea Ambrosini-Spaltro et al.

APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2012)

Review Pathology

EGFR Mutations and Lung Cancer

Gilda da Cunha Santos et al.

ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 6 (2011)

Article Oncology

Heterogeneous Distribution of EGFR Mutations Is Extremely Rare in Lung Adenocarcinoma

Yasushi Yatabe et al.

JOURNAL OF CLINICAL ONCOLOGY (2011)

Article Medicine, General & Internal

Gefitinib or Carboplatin-Paclitaxel in Pulmonary Adenocarcinoma.

Tony S. Mok et al.

NEW ENGLAND JOURNAL OF MEDICINE (2009)

Review Medicine, General & Internal

Drug therapy: EGFR antagonists in cancer treatment

Fortunato Ciardiello et al.

NEW ENGLAND JOURNAL OF MEDICINE (2008)

Article Medical Laboratory Technology

Cytomorphological correlates of epidermal growth factor receptor mutations in lung carcinoma

Elena F. Brachtel et al.

DIAGNOSTIC CYTOPATHOLOGY (2007)

Review Respiratory System

Management of malignant pleural effusions

VB Antony et al.

EUROPEAN RESPIRATORY JOURNAL (2001)